Detlev Ganten
After finishing school with a high school diploma, he studied medicine in Würzburg, Montpellier (France) and Tübingen and then conducted research for several years in Montreal (Canada) at the Clinical Research Institute. In 1970 he passed his medical license. Ganten earned the title of PhD (Doctor of Philosophy) at McGill University Montreal in 1973. This was followed by his habilitation and professorship at the University of Heidelberg. He also worked at the Pharmacological Institute at Heidelberg University.
In 1990 he was awarded the Max Planck Research Prize and the Okamoto Prize, Japan. In 1992, Ganten received the CIBA Award from the Council for High Blood Pressure Research, American Heart Association. From 1992 to 1998 he became president of the World Hypertension League. Meanwhile, he was a member of the scientific committee of the Health Research Council (1992-1997) and its Science Council from 1993 to 1998. From 1996 to 1998 he served as President of the Society of German Natural Scientists and Doctors (GDNÄ). From 1997 to 2001, Ganten became chairman of the Hermann von Helmholtz Association of German Research Centers.
His research focus became the hormonal regulation of blood pressure, particularly the renin-angiotensin system, and the molecular genetics of cardiovascular diseases. From 1991 to 2004, Ganten served as founding director of the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, for whose development he was largely responsible. The MDC, founded in 1992, emerged from three central institutes of the GDR Academy of Sciences in Berlin-Buch. It was possible to build a center for clinical research that is unique in the Federal Republic on the Berlin-Buch campus.
From February 2004 to September 2008, Prof. Dr. med. Detlev Ganten is the chairman of the board of the "Charité - Universitätsmedizin Berlin". With 15,000 employees and 3,500 beds, the Charité is the largest university hospital in Europe. In this position, Ganten is implementing the merger of the Benjamin Franklin and Charité University Hospitals, which was previously passed by law and initiated by the Berlin House of Representatives in 2003. As chairman of the supervisory board of the "BBB Biomedical Research Campus Berlin-Buch Management GmbH", Prof. Ganten was also significantly involved in the development of a biotechnology park.
This enabled a modern research complex to be created in Berlin-Buch, from basic research to clinical application. His scientific work includes numerous publications and books. Prof. Dr. med. Detlef Ganten became a member of the Heidelberg Academy of Sciences, the Polish Academy of Sciences, the Academia Europea, the Berlin-Brandenburg Academy of Sciences, the German Academy of Natural Scientists Leopoldina, and the Russian Academy of Medical Sciences. He is a recipient of the Federal Cross of Merit and a knight of the French "Legion d'honneur".
In 1990 he was awarded the Max Planck Research Prize and the Okamoto Prize, Japan. In 1992, Ganten received the CIBA Award from the Council for High Blood Pressure Research, American Heart Association. From 1992 to 1998 he became president of the World Hypertension League. Meanwhile, he was a member of the scientific committee of the Health Research Council (1992-1997) and its Science Council from 1993 to 1998. From 1996 to 1998 he served as President of the Society of German Natural Scientists and Doctors (GDNÄ). From 1997 to 2001, Ganten became chairman of the Hermann von Helmholtz Association of German Research Centers.
His research focus became the hormonal regulation of blood pressure, particularly the renin-angiotensin system, and the molecular genetics of cardiovascular diseases. From 1991 to 2004, Ganten served as founding director of the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, for whose development he was largely responsible. The MDC, founded in 1992, emerged from three central institutes of the GDR Academy of Sciences in Berlin-Buch. It was possible to build a center for clinical research that is unique in the Federal Republic on the Berlin-Buch campus.
From February 2004 to September 2008, Prof. Dr. med. Detlev Ganten is the chairman of the board of the "Charité - Universitätsmedizin Berlin". With 15,000 employees and 3,500 beds, the Charité is the largest university hospital in Europe. In this position, Ganten is implementing the merger of the Benjamin Franklin and Charité University Hospitals, which was previously passed by law and initiated by the Berlin House of Representatives in 2003. As chairman of the supervisory board of the "BBB Biomedical Research Campus Berlin-Buch Management GmbH", Prof. Ganten was also significantly involved in the development of a biotechnology park.
This enabled a modern research complex to be created in Berlin-Buch, from basic research to clinical application. His scientific work includes numerous publications and books. Prof. Dr. med. Detlef Ganten became a member of the Heidelberg Academy of Sciences, the Polish Academy of Sciences, the Academia Europea, the Berlin-Brandenburg Academy of Sciences, the German Academy of Natural Scientists Leopoldina, and the Russian Academy of Medical Sciences. He is a recipient of the Federal Cross of Merit and a knight of the French "Legion d'honneur".